Skip to main content
Erschienen in: Cancer Microenvironment 1/2011

01.04.2011 | Original Paper

Effect of Increased Extracellular Ca++ on Microvesicle Production and Tumor Spheroid Formation

verfasst von: Sarah Crawford, Deanna Diamond, Laura Brustolon, Rafaela Penarreta

Erschienen in: Cancer Microenvironment | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Research on the composition of the tumor micro-environment has demonstrated that membrane delimited microvesicles are shed from many types of malignant tumors, in the peripheral blood of cancer patients as well as in culture media of tumor cells propagated in vitro (Ginestra et al. Anticancer Res 18:3433–3437, 1998). Their documented effects involve the activation of signal transduction pathways by cellular cross-talk that are associated with epigenetic mechanisms that may be important in tumor progression, metastasis, and the activation of angiogenesis (Distler et al. Arthritis Rheum 52:3337–3348, 2005). Live cell imaging microscopic studies conducted in our laboratory of the formation of solid tumor spheroids in vitro show that the shedding of microvesicular structures from tumor cells occurs during this process. The observed properties of the tumor microvesicles suggest a role in solid tumor formation and intercellular communication. The tumor associated microvesicles were shown to be non-apoptotic based on the absence of fluorescent nuclear staining by acridine orange/ethidium bromide staining. Increased concentration of extracellular Ca++ [5–20 mM] resulted in an increase in the production of tumor-derived microvesicles and also to result in the formation of tumor spheroids whose size was considerably smaller than controls. Increased extracellular [Ca++] was also observed to induce the rapid dissociation of solid tumor spheroids to smaller cell aggregates in the absence of significant apoptosis.
Literatur
1.
Zurück zum Zitat Ginestra A, LaPlaca MD, Saladino F et al (1998) The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18:3433–3437PubMed Ginestra A, LaPlaca MD, Saladino F et al (1998) The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18:3433–3437PubMed
2.
Zurück zum Zitat Distler JH, Pisetsky DS, Huber LC et al (2005) Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 52:3337–3348PubMedCrossRef Distler JH, Pisetsky DS, Huber LC et al (2005) Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 52:3337–3348PubMedCrossRef
3.
Zurück zum Zitat Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288PubMedCrossRef Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288PubMedCrossRef
4.
Zurück zum Zitat Beaudoin AR, Grondin G (1991) Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim Biophys Acta 10:171–203 Beaudoin AR, Grondin G (1991) Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim Biophys Acta 10:171–203
5.
Zurück zum Zitat Horstman LL, Jimenez JJ, Bidot C, Ahn YS (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53:210–230PubMedCrossRef Horstman LL, Jimenez JJ, Bidot C, Ahn YS (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53:210–230PubMedCrossRef
6.
Zurück zum Zitat Skog J, Wurdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–1476PubMedCrossRef Skog J, Wurdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–1476PubMedCrossRef
7.
Zurück zum Zitat Muralidharan-Chari V, Clancy J, Sedgwick A et al (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611PubMedCrossRef Muralidharan-Chari V, Clancy J, Sedgwick A et al (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611PubMedCrossRef
8.
Zurück zum Zitat Valenti R, Huber V, Manuela I et al (2006) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67:2912CrossRef Valenti R, Huber V, Manuela I et al (2006) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67:2912CrossRef
9.
Zurück zum Zitat Tl W (2005) Tumor-derived exosomes or microvesicles: another mechanism of tumor escape from the host immune system? Br J Cancer 92:209–211CrossRef Tl W (2005) Tumor-derived exosomes or microvesicles: another mechanism of tumor escape from the host immune system? Br J Cancer 92:209–211CrossRef
10.
Zurück zum Zitat George JN, Thoi LL, McManus LM et al (1982) Isolation of human membrane microparticles from plasma and serum. Blood 60:834PubMed George JN, Thoi LL, McManus LM et al (1982) Isolation of human membrane microparticles from plasma and serum. Blood 60:834PubMed
11.
Zurück zum Zitat Yu X, Harris SL, Levine AJ (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66:4795–4801PubMedCrossRef Yu X, Harris SL, Levine AJ (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66:4795–4801PubMedCrossRef
12.
Zurück zum Zitat Ginestra A, Miceli D, Dolo V et al (1999) Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19:3439–3446PubMed Ginestra A, Miceli D, Dolo V et al (1999) Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19:3439–3446PubMed
13.
Zurück zum Zitat DiVizio D, Kim J, Hager M et al (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69:5601–5609CrossRef DiVizio D, Kim J, Hager M et al (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69:5601–5609CrossRef
14.
Zurück zum Zitat Vidulescu C, Clejan S, O’Connor KC (2004) Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells. J Cell Mol Med 8:388–396, 14PubMedCrossRef Vidulescu C, Clejan S, O’Connor KC (2004) Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells. J Cell Mol Med 8:388–396, 14PubMedCrossRef
15.
Zurück zum Zitat Janoska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:3143–3149 Janoska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:3143–3149
16.
Zurück zum Zitat Barry OP, Fitzgerald GA (1999) Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 82:794–800PubMed Barry OP, Fitzgerald GA (1999) Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 82:794–800PubMed
17.
Zurück zum Zitat Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 8:177–184CrossRef Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 8:177–184CrossRef
18.
Zurück zum Zitat Francia G, Green S, Kerbel R (2005) Epigenetic aspects of environmentally mediated “multicellular” drug resistance. Am Assoc Cancer Res Educ Book, pp 114–118 Francia G, Green S, Kerbel R (2005) Epigenetic aspects of environmentally mediated “multicellular” drug resistance. Am Assoc Cancer Res Educ Book, pp 114–118
19.
Zurück zum Zitat Espina V, Mariani B, Gallgher R et al (2010) Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS ONE 5:e10240PubMedCrossRef Espina V, Mariani B, Gallgher R et al (2010) Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS ONE 5:e10240PubMedCrossRef
20.
Zurück zum Zitat DeRoos M, van der Vegt B, de Vries J et al (2007) Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 14:2097–2104, 20CrossRef DeRoos M, van der Vegt B, de Vries J et al (2007) Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 14:2097–2104, 20CrossRef
21.
22.
Zurück zum Zitat Hotte S, Hirte H, Rabbani S, Carling T, Hendy G, Major P (2002) Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment. Am J Cancer 1:179–187CrossRef Hotte S, Hirte H, Rabbani S, Carling T, Hendy G, Major P (2002) Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment. Am J Cancer 1:179–187CrossRef
23.
Zurück zum Zitat Davidson TG (2001) Conventional treatment of hypercalcemia of malignancy. Am J Health-Syst Pharm 15:S8–S15, 23 Davidson TG (2001) Conventional treatment of hypercalcemia of malignancy. Am J Health-Syst Pharm 15:S8–S15, 23
24.
Zurück zum Zitat Sidler B, Alpert L, Henderson JE, Deckelbaum R, Amizuka N, Silva JE, Goltzman D, Karaplis AC (1996) Amplification of the parathyroid hormone-related peptide gene in a colonic carcinoma. J Clin Endocrinol Metab 81:2841–2847PubMedCrossRef Sidler B, Alpert L, Henderson JE, Deckelbaum R, Amizuka N, Silva JE, Goltzman D, Karaplis AC (1996) Amplification of the parathyroid hormone-related peptide gene in a colonic carcinoma. J Clin Endocrinol Metab 81:2841–2847PubMedCrossRef
25.
Zurück zum Zitat Anderson J, Grabowska A, Watson S (2007) PTHrP increases transcriptional activity of the integrin subunit α 5. Br J Cancer 96:1394–1403PubMed Anderson J, Grabowska A, Watson S (2007) PTHrP increases transcriptional activity of the integrin subunit α 5. Br J Cancer 96:1394–1403PubMed
26.
Zurück zum Zitat Suva LJ, Winslow GA, Wettenhall RE et al (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–896PubMedCrossRef Suva LJ, Winslow GA, Wettenhall RE et al (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–896PubMedCrossRef
Metadaten
Titel
Effect of Increased Extracellular Ca++ on Microvesicle Production and Tumor Spheroid Formation
verfasst von
Sarah Crawford
Deanna Diamond
Laura Brustolon
Rafaela Penarreta
Publikationsdatum
01.04.2011
Verlag
Springer Netherlands
Erschienen in
Cancer Microenvironment / Ausgabe 1/2011
Print ISSN: 1875-2292
Elektronische ISSN: 1875-2284
DOI
https://doi.org/10.1007/s12307-010-0049-0

Weitere Artikel der Ausgabe 1/2011

Cancer Microenvironment 1/2011 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.